These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37776482)

  • 41. Efficacy and safety of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.
    Anno S; Okano T; Mamoto K; Yamada Y; Mandai K; Orita K; Iida T; Tada M; Inui K; Koike T; Nakamura H
    Mod Rheumatol; 2024 Aug; ():. PubMed ID: 39215592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology.
    Fornaro M; Benaglio F; Montecucco C; Raffeiner B; Di Franco M; Iannuccelli C; Conigliaro P; Lomater C; Govoni M; Silvagni E; Zanetti A; Parisi S; Carrara G; Scirè CA; Caporali R; Iannone F
    Clin Exp Rheumatol; 2022 Sep; 40(9):1693-1700. PubMed ID: 35084309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
    Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
    Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.
    Singh JA; Cameron DR
    J Manag Care Pharm; 2012 May; 18(4 Supp C):S1-18. PubMed ID: 22656072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort.
    Perrotta FM; Scriffignano S; Ciccia F; Lubrano E
    Rheumatol Ther; 2022 Aug; 9(4):1193-1201. PubMed ID: 35612694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Core management principles in rheumatoid arthritis to help guide managed care professionals.
    Agarwal SK
    J Manag Care Pharm; 2011; 17(9 Suppl B):S03-8. PubMed ID: 22073933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.
    van Hulst LT; Kievit W; van Bommel R; van Riel PL; Fraenkel L
    Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1407-14. PubMed ID: 21748861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incorporating the treat-to-target concept in rheumatoid arthritis.
    Ruderman EM; Nola KM; Ferrell S; Sapir T; Cameron DR
    J Manag Care Pharm; 2012; 18(9):1-18. PubMed ID: 23206239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
    Alhajeri H; Abutiban F; Al-Adsani W; Al-Awadhi A; Aldei A; AlEnizi A; Alhadhood N; Al-Herz A; Alkandari W; Dehrab A; Muhanna Ghanem AA; Hasan E; Hayat S; Saleh K; Tarakmeh H; Ali Y
    Rheumatol Int; 2019 Sep; 39(9):1483-1497. PubMed ID: 31309293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria.
    van der Heijde D; van der Helm-van Mil AH; Aletaha D; Bingham CO; Burmester GR; Dougados M; Emery P; Felson D; Knevel R; Kvien TK; Landewé RB; Lukas C; McInnes I; Silman AJ; Smolen JS; Stanislawska-Biernat E; Zink A; Combe B
    Ann Rheum Dis; 2013 Apr; 72(4):479-81. PubMed ID: 23378540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Difficult-to-treat rheumatoid arthritis].
    Alromaih FJ; Dumusc A
    Rev Med Suisse; 2024 Mar; 20(865):541-545. PubMed ID: 38482760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2023 Management Recommendations of Bangladesh Rheumatology Society on Pharmacological Treatment of Rheumatoid Arthritis With Synthetic and Biologic Disease-Modifying Drugs.
    Momen Majumder MS; Hasan ATMT; Choudhury MR; Ahmed S; Miah MT; Amin MR; Shahin MA; Islam A; Shazzad MN; Hassan MM; Ahmedullah AK; Rahman MM; Yesmeen S; Uddin T; Haq SA
    Cureus; 2024 Apr; 16(4):e59395. PubMed ID: 38707172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New Rheumatoid Arthritis Treatments for 'Old' Patients: Results of a Systematic Review.
    Caporali R; Fakhouri WKH; Nicolay C; Longley HJ; Losi S; Rogai V
    Adv Ther; 2020 Sep; 37(9):3676-3691. PubMed ID: 32705531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
    Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
    Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying antirheumatic drug receipt.
    Polinski JM; Brookhart MA; Ayanian JZ; Katz JN; Kim SC; Lii J; Tonner C; Yelin E; Solomon DH
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1634-43. PubMed ID: 24664991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    Louthrenoo W; Kasitanon N; Katchamart W; Aiewruengsurat D; Chevaisrakul P; Chiowchanwisawakit P; Dechanuwong P; Hanvivadhanakul P; Mahakkanukrauh A; Manavathongchai S; Muangchan C; Narongroeknawin P; Phumethum V; Siripaitoon B; Suesuwan A; Suwannaroj S; Uea-Areewongsa P; Ukritchon S; Asavatanabodee P; Koolvisoot A; Nanagara R; Totemchokchyakarn K; Nuntirooj K; Kitumnuaypong T
    Int J Rheum Dis; 2017 Sep; 20(9):1166-1184. PubMed ID: 28730640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey.
    Roodenrijs NMT; de Hair MJH; van der Goes MC; Jacobs JWG; Welsing PMJ; van der Heijde D; Aletaha D; Dougados M; Hyrich KL; McInnes IB; Mueller-Ladner U; Senolt L; Szekanecz Z; van Laar JM; Nagy G;
    Ann Rheum Dis; 2018 Dec; 77(12):1705-1709. PubMed ID: 30194273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical remission in rheumatoid arthritis and psoriatic arthritis.
    Lubrano E; Mesina F; Caporali R
    Clin Exp Rheumatol; 2018; 36(5):900-910. PubMed ID: 29600949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
    Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G
    J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.